Press release
Biostimulants Market is Projected to Offer Huge Growth Potential by 2025
The biostimulants market is estimated to account for USD 2.6 billion in 2019 and is projected to reach USD 4.9 billion by 2025, at a CAGR of 11.24% during the forecast period. The market is primarily driven by the strong market demand for high-value crops across the globe and the increasing need to support crop growth due to abiotic stress, arising from changing climatic conditions. In addition, technological advancements by the key players in most of the regions have led to high demand for biostimulant products.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1081
On the basis of active ingredient, the amino acids segment has been estimated to occupy the major share, in terms of value, in 2019.
Price differences in active ingredients is a major factor, due to which, the amino acids segment is projected to remain dominant in the market, in terms of value. In terms of volume, the dosage rate plays an integral role in the effectiveness of biostimulants. Since the dosage rate of humic substances is much higher in comparison, as they are mostly preferred for foliar applications, they dominate the market, in terms of volume, in 2018. Earlier, biostimulant products were majorly offered as a single active ingredient, which imparted specific functions such as stress tolerance or enhancement of crop quality. However, due to intense research on this market, formulations for blending multiple active ingredients have been developed by players such as Valagro (Italy).
The increasing awareness of nutritional benefits associated with biostimulants and their application on broad-acre crops have widened the scope of growth within the market.
The usage of biostimulants has evolved immensely from high-value crops such as fruits & vegetables to broad-acre crops such as cereals, pulses, and fiber crops. It has been observed that biostimulants enhance the uptake of nutrients, develop tolerance to abiotic stresses, and increase the vigor and yield of crops such as wheat, rice, and barley. The immense possibility in the application of biostimulants for these broad-acre crops can lead to the significant growth of this market. Many domestic manufacturers have begun to realize the prospective demand in the coming years, with several launches targeted on crops such as rice, corn, and wheat.
On the basis of form, the liquid segment is projected to witness higher growth in the biostimulants market.
Various factors, such as the type of crop, type of storage available, size of the field, and weather conditions in the region, are attributable to the selection of the form, in which, biostimulants ought to be used. Most biostimulants are available in the liquid form. However, dry soluble formulations are also being made available, owing to their ease of handling and increased shelf life. Suspension concentrate formulations are the most commonly available liquid form of biostimulants. Major companies that manufacture liquid-based biostimulants include Ilsa (acquired by Italy-based Biolchim), UPL (US), Koppert (Netherlands), BioAg Alliance [Monsanto (US), and Novozymes (Denmark).
Asia Pacific is projected to witness the highest growth in the biostimulants market during the forecast period.
The global market was dominated by Europe, in terms of value, in 2018, due to the adoption of modern agricultural technology such as precision farming and plant biotechnology, and organic-based active ingredients. However, the demand for biostimulants in developing regions such as Asia Pacific and South America has significantly increased. According to FAOSTAT, in 2016, the Asia Pacific occupied 36.4% of the global agriculture land. The agriculture industry in Asia, particularly in the Southeast Asian countries, has witnessed effective transformation due to various technological advancements. Significant adoption of biostimulants can be witnessed in China, India, Australia, Japan, and Indonesia. Moreover, commercial seaweed cultivation provides further growth opportunities in the region. Innovative companies such as Sea6 Energy (India) are exclusively offering seaweed-based biostimulants along with technological platforms such as TARMA and SPURT.
Make an Inquiry: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=1081
There are many domestic and global players that provide biostimulants for a wide range of crops across the world. Major manufacturers are based in Europe and Asian countries. In multiple regions, due to unclear regulation, an ambiguity exists between biostimulants and biofertilizers. Hence, the scope of this report includes a detailed study of those biostimulant manufacturers, whose portfolios mention the products as biostimulants. Key companies in the global market are BASF (Germany), Isagro (Italy), Valagro (Italy), Bayer (Germany), Italpollina (Italy), Koppert Biological Systems (Netherlands), Acadian Seaplants (Canada), UPL (India), and Biolchim (Italy). Various strategies such as acquisitions, joint ventures, and new product launches were adopted by the companies to enter the biostimulants market.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biostimulants Market is Projected to Offer Huge Growth Potential by 2025 here
News-ID: 2428649 • Views: …
More Releases from Markets and Markets

Controlled-release Fertilizers Market Latest Trends, Demands, Overview and Analy …
The controlled-release fertilizers market is experiencing notable growth, estimated at USD 2.2 billion in 2023 and projected to reach USD 2.9 billion by 2028. This reflects a compound annual growth rate (CAGR) of 5.9% during the forecast period. The demand for controlled-release fertilizers is increasing due to their benefits in enhancing nutrient efficiency, reducing environmental impact, and supporting sustainable agricultural practices.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=136099624
These fertilizers are prized for their ability…

Gelatin Market is Projected to Reach $5.6 billion by 2029, at a CAGR of 6.9% fro …
According to a research report titled "Gelatin Market by Source (Animal, Plants), By Applications (Food & Beverages, Pharmaceuticals, Health & Nutrition, Cosmetics, Personal Care, Animal Feed), Type (Type A, Type B), Function (Thickener, Stabilizer, Gelling Agent) - Global Forecast to 2029," published by MarketsandMarkets, the gelatin market is poised for significant growth. The market, valued at USD 4.0 billion in 2024, is projected to reach USD 5.6 billion by 2029,…

Facility Management Market Status, Revenue, Growth Rate, Services and Solutions
According to a research report "Facility Management Market by Offering (Solutions (IWMS, BIM, Facility Operations & Security Management) and Services), Vertical (BFSI, Retail, Construction & Real Estate, Healthcare & Life sciences) and Region - Global Forecast to 2028" published by MarketsandMarkets, the facility management market is estimated at USD 49.6 billion in 2023 to USD 94.8 billion by 2028, at a Compound Annual Growth Rate (CAGR) of 13.8%.
Download PDF Brochure:…

Endpoint Security Market Size, Revenue, Growth Rate Analysis and Forecast 2024
According to a research report "Endpoint Security Market by Solution (Endpoint Protection Platform and Endpoint Detection and Response), Service, Deployment Mode, Organization Size, Vertical (Healthcare, Retail and eCommerce, and Government), and Region - Global Forecast to 2024", published by MarketsandMarkets, the global endpoint security market size is expected to grow from USD 12.8 billion in 2019 to USD 18.4 billion by 2024, at a Compound Annual Growth Rate (CAGR) of…
More Releases for MarketsandMarkets™
Biomaterials Market Worth $64.2 billion | MarketsandMarkets™
Biomaterials Market in terms of revenue was estimated to be worth $45.2 billion in 2024 and is poised to reach $64.2 billion by 2029, growing at a CAGR of 7.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. The biomaterials market is estimated to grow at a CAGR of 7.3% during the forecast period of 2024 to 2029. The important factors impacting market growth are the growing…
Cell Expansion Market Worth $26.7 billion | MarketsandMarkets™
Cell Expansion Market in terms of revenue was estimated to be worth $14.3 billion in 2024 and is poised to reach $26.7 billion by 2029, growing at a CAGR of 13.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. Some factors contributing to the growth of the global market includes increasing R&D investments in cell based research, growing focus on personalized medicine, and increasing number of strategic…
Apheresis Market Worth $3.9 billion | MarketsandMarkets™
Apheresis Market in terms of revenue was estimated to be worth $2.6 billion in 2024 and is poised to reach $3.9 billion by 2029, growing at a CAGR of 8.8% from 2024 to 2029 according to a new report by MarketsandMarkets™.
The growth in the apheresis market is driven by rise in demand for source plasma from biopharmaceutical companies, upsurging demand for blood components and favourable reimbursement for apheresis. The increasing…
Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market in terms of revenue was estimated to be worth $16.0 billion in 2024 and is poised to reach $33.8 billion by 2029, growing at a CAGR of 16.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the medical robots market is driven by the aging population and rising chronic diseases, improving reimbursement scenario, and subsequent advancements in healthcare funding & infrastructure.…
Pipette Calibrators Market Worth $391 million | MarketsandMarkets™
Pipette Calibrators Market in terms of revenue was estimated to be worth $286 million in 2024 and is poised to reach $391 million by 2029, growing at a CAGR of 6.5% from 2024 to 2029 according to a new report by MarketsandMarkets™.
The growth of this market is majorly driven by rise in genomics and proteomics research, growth in portable and handheld devices, and establishment of new research facilities by pharmaceutical…
Mice Model Market Worth $2.2 billion | MarketsandMarkets™
Mice Model Market in terms of revenue was estimated to be worth $1.5 billion in 2024 and is poised to reach $2.2 billion by 2029, growing at a CAGR of 8.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The rise in chronic diseases, such as cancer, diabetes, and cardiovascular disorders, and growing need for reliable and predictive animal models to facilitate drug discovery and development are…